124 related articles for article (PubMed ID: 17488679)
1. Current role of allogeneic stem cell transplantation in follicular lymphoma.
Farina L; Corradini P
Haematologica; 2007 May; 92(5):580-2. PubMed ID: 17488679
[No Abstract] [Full Text] [Related]
2. Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy.
van Besien K
Hematology Am Soc Hematol Educ Program; 2009; ():610-8. PubMed ID: 20008246
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of hematopoietic stem cell transplantation for multiple myeloma].
Shimazaki C
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1331-6. PubMed ID: 16097588
[No Abstract] [Full Text] [Related]
4. Reduced intensity transplantation: where are we now?
Mackinnon S; Thomson K; Morris E; Kottaridis PD; Peggs KS
Hematol J; 2004; 5 Suppl 3():S34-8. PubMed ID: 15190275
[No Abstract] [Full Text] [Related]
5. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
6. Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma.
Tam CS; Khouri I
Curr Hematol Malig Rep; 2007 Oct; 2(4):225-31. PubMed ID: 20425374
[TBL] [Abstract][Full Text] [Related]
7. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
8. Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation.
Hsieh MM; Fitzhugh CD; Tisdale JF
Blood; 2009 Jul; 114(1):225; author reply 225-6. PubMed ID: 19574484
[No Abstract] [Full Text] [Related]
9. Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.
Bhatt VR; Armitage JO
Expert Opin Biol Ther; 2016; 16(1):57-66. PubMed ID: 26515478
[TBL] [Abstract][Full Text] [Related]
10. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
11. Intensive therapies in follicular non-Hodgkin lymphomas.
Hunault-Berger M; Ifrah N; Solal-Celigny P;
Blood; 2002 Aug; 100(4):1141-52. PubMed ID: 12149190
[No Abstract] [Full Text] [Related]
12. Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
Deeg HJ; Socie G
Blood; 1998 Mar; 91(6):1833-44. PubMed ID: 9490664
[No Abstract] [Full Text] [Related]
13. The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma.
Kuruvilla J
Blood; 2016 Apr; 127(17):2093-100. PubMed ID: 26989206
[TBL] [Abstract][Full Text] [Related]
14. T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.
Thomson KJ; Morris EC; Milligan D; Parker AN; Hunter AE; Cook G; Bloor AJ; Clark F; Kazmi M; Linch DC; Chakraverty R; Peggs KS; Mackinnon S
J Clin Oncol; 2010 Aug; 28(23):3695-700. PubMed ID: 20606089
[TBL] [Abstract][Full Text] [Related]
15. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Feinstein L; Sandmaier B; Maloney D; McSweeney PA; Maris M; Flowers C; Radich J; Little MT; Nash RA; Chauncey T; Woolfrey A; Georges G; Kiem HP; Zaucha JM; Blume KG; Shizuru J; Niederwieser D; Storb R
Ann N Y Acad Sci; 2001 Jun; 938():328-37; discussion 337-9. PubMed ID: 11458521
[TBL] [Abstract][Full Text] [Related]
16. Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum.
van Besien K
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2035-2036. PubMed ID: 26463649
[No Abstract] [Full Text] [Related]
17. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
Peggs KS; Mackinnon S; Williams CD; D'Sa S; Thuraisundaram D; Kyriakou C; Morris EC; Hale G; Waldmann H; Linch DC; Goldstone AH; Yong K
Biol Blood Marrow Transplant; 2003 Apr; 9(4):257-65. PubMed ID: 12720218
[TBL] [Abstract][Full Text] [Related]
18. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
Vigouroux S; Michallet M; Porcher R; Attal M; Ades L; Bernard M; Blaise D; Tabrizi R; Garban F; Cassuto JP; Chevalier P; Facon T; Ifrah N; Renaud M; Tilly H; Vernant JP; Kuentz M; Bourhis JH; Bordigoni P; Deconinck E; Lioure B; Socié G; Milpied N;
Haematologica; 2007 May; 92(5):627-34. PubMed ID: 17488686
[TBL] [Abstract][Full Text] [Related]
20. Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis.
Busemann C; Neumann T; Schulze M; Klenner A; Thiele T; Greinacher A; Dölken G; Krüger WH
Ann Hematol; 2013 Jul; 92(7):945-52. PubMed ID: 23463451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
